Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ferring Pharmaceuticals Inc.

Division of Ferring Pharmaceuticals AS
www.ferringusa.com

Latest From Ferring Pharmaceuticals Inc.

Pediatric Testosterone Therapy: Sponsors Wary Of Trials Despite PREA

Studies are unfeasible, sponsors argue in advance of US advisory committee meeting that could lead to FDA ending its waiver on requiring clinical trials in pediatric patients for new testosterone replacement therapy products.
Advisory Committees Clinical Trials

Pacts In Medtech: Amarantus And Todos Form Breakthrough Diagnostics Inc.; Edwards Teams Up With Bay Labs To Find Heart Disease

Derived from Strategic Transactions, Informa's premium source for tracking life-sciences deals, the bimonthly Pacts In Medtech feature highlights notable technology alliances, R&D partnerships and commercial collaborations. This edition covers industry pacts that were sealed in November and December 2018.

Pacts in Medtech Deals

FDA Wins Abilify Exclusivity Battle; Court Rejects Otsuka's 'Legal Equivalence'

Otsuka claimed Alkermes' Aristada is 'legally equivalent' to Abilify but DC Circuit deferred to FDA's finding that the two have different active moieties and thus Abilify's three-year exclusivity does not apply to Aristada.

Intellectual Property Legal Issues

Provenge To Drive Sanpower Growth And Wider China Cell Therapy Market?

China will provide a rising market potential for Sanpower’s newly acquired Dendreon and its Provenge product for prostate cancer, as part of the Chinese firm’s broader strategy, and the deal could also have an impact on the regulatory climate for cellular immunotherapies in China.

China Commercial
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Ferring Pharmaceuticals AS
  • Senior Management
  • Vladimir Yankov, MD, VP, Clin. R&D
  • Contact Info
  • Ferring Pharmaceuticals Inc.
    Phone: (973) 796-1600
    100 Interpace Pkwy.
    Parsippany, NJ 07054
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register